PATH
UiPath Inc.
PATH's fundamentals are strong: its operating margin went from −3.1% to 8.9% and it turned 21% of its revenue into free cash flow. At 20x earnings, it's trading below its usual 23x. Analysts expect earnings growth.
PATH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
PATH's revenue, profitability, cash flow and balance sheet are all currently healthy.
PATH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $13.10 | — |
| Cheap | 20x | $13.08 | -0.2% |
| Current | 20x | $13.10 | — |
| Fair | 23x | $15.26 | +16% |
| Expensive | 403x | $270 | +1960% |
Historical ranges are pointers, not guarantees.
PATH's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
PATH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for PATH, with profitability improving.
PATH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | +31% |
| Q3 2026 | $0.67 | +2133% |
| Q2 2026 | $0.60 | +$0.72 |
| Q1 2026 | $0.52 | +$0.65 |
| Q4 2025 | $0.42 | +$0.57 |
| Q3 2025 | $0.03 | +$0.22 |
| Q2 2025 | -$0.12 | +$0.03 |
| Q1 2025 | -$0.13 | +$0.03 |
| Q4 2024 | -$0.15 | +$0.13 |
PATH's earnings per share have climbed steadily: $0.67 over the past year, more than ten times what it earned the year before, and higher year over year for 18 quarters in a row.
PATH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $410.3M | +13% |
| Q2 2026 | $418.4M | +17% |
| Q1 2026 | $481.1M | +14% |
| Q4 2025 | $411.1M | +16% |
| Q3 2025 | $361.7M | +14% |
| Q2 2025 | $356.6M | +6.4% |
| Q1 2025 | $423.6M | +4.5% |
| Q4 2024 | $354.7M | +8.8% |
PATH's revenue has grown year over year every quarter since early 2021: $410M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.7% | +13 points |
| Q2 2026 | 6.7% | +11 points |
| Q1 2026 | 17% | +8.8 points |
| Q4 2025 | 3.2% | +15 points |
| Q3 2025 | -5.6% | +27 points |
| Q2 2025 | -4.6% | +10 points |
| Q1 2025 | 7.9% | +4.2 points |
| Q4 2024 | -12% | +4.9 points |
PATH's operating margin was 7.7% last quarter, up 13 points from the same quarter a year ago.
PATH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $29.3M | -30% |
| Q2 2026 | $129.2M | +22% |
| Q1 2026 | $179.3M | +29% |
| Q4 2025 | $25.1M | +8.2% |
| Q3 2025 | $41.6M | -7.5% |
| Q2 2025 | $106.2M | +7.5% |
| Q1 2025 | $138.7M | -2.2% |
| Q4 2024 | $23.2M | -44% |
PATH generated $363M in free cash flow over the past year, up 17% from the year before.
PATH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -4.8M shares |
| 1 year | -3.7% | -19.9M shares |
| 3 years | -7.1% | -39.9M shares |
| 5 years | -0.7% | -3.5M shares |
| Available history | +6.3% | +30.9M shares |
PATH has 523M diluted shares, down 3.7% from a year ago, with $269M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $24.8M |
| Q2 2026 | $243.8M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $101.6M |
| Q2 2025 | $227.5M |
| Q1 2025 | $9.3M |
| Q4 2024 | $162.7M |
PATH spent $269M buying back its own shares over the past year, down 46% from the year before.
PATH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.4x | Net Cash |
| Q2 2026 | -5.2x | Net Cash |
| Q1 2026 | -11.8x | Net Cash |
| Q4 2025 | -29.4x | Net Cash |
PATH has more cash than debt.
PATH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.6 | Neutral |
| Stochastic | 24.9 | Neutral |
PATH's weekly RSI is 50 (neutral) and its Stochastic is 25 (neutral).
PATH PE vs Technology Sector
| Metric | PATH | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 28x | 30% below |
| PE % | 20 | 42 | 22 pts below |
PATH is trading at 20x earnings, a 30% discount to the Technology sector's median of 28x.
PATH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.2 | 1% below |
| 20 week MA | $13.7 | 4% below |
| 50 week MA | $12.9 | 1.4% above |
| 100 week MA | $12.8 | 2.3% above |
| 200 week MA | $14.8 | 12% below |
PATH's trend is mixed: it's above two of its five weekly moving averages, and 12% below its 200-week average.
PATH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $74.8 | $44.4 | -41% |
| 2022 | $44.4 | $12.1 | -73% |
| 2023 | $12.1 | $24.8 | +105% |
| 2024 | $24.8 | $12.9 | -48% |
| 2025 | $12.9 | $16.8 | +31% |
| 2026 YTD | $16.8 | $13.1 | -22% |
PATH's yearly returns have swung widely, from +105% in 2023 to −73% in 2022. It's down 22% so far in 2026.